D.E. Shaw & Co’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-45,238
Closed -$96.4K 4355
2025
Q1
$96.4K Sell
45,238
-71,415
-61% -$243K ﹤0.01% 4025
2024
Q4
$453K Buy
+116,653
New +$930K ﹤0.01% 3674
2024
Q1
Sell
-52,994
Closed -$769K 4355
2023
Q4
$769K Buy
+52,994
New +$644K ﹤0.01% 3304
2023
Q3
Sell
-75,579
Closed -$1.66M 4259
2023
Q2
$1.66M Sell
75,579
-142,008
-65% -$4.45M ﹤0.01% 2751
2023
Q1
$6.75M Buy
217,587
+136,594
+169% +$1.7M 0.01% 1691
2022
Q4
$683K Buy
80,993
+2,911
+4% +$24.8K ﹤0.01% 3681
2022
Q3
$764K Buy
78,082
+57,167
+273% +$656K ﹤0.01% 3776
2022
Q2
$251K Buy
+20,915
New +$122K ﹤0.01% 4444
2022
Q1
Sell
-20,955
Closed -$156K 5545
2021
Q4
$156K Buy
+20,955
New +$222K ﹤0.01% 4953

Other funds holding BMEA

D.E. Shaw & Co's BMEA Position: Q2 2025 in Review

D.E. Shaw & Co sold out of Biomea Fusion (BMEA) in Q2 2025, closing a stake of 45,238 shares — an estimated $96.4K sold.

D.E. Shaw & Co first reported a position in BMEA in Q4 2021 and held it in 9 quarters. The position peaked at $6.75M in Q1 2023. 87 funds tracked by Wall St. Rank hold BMEA as of Q2 2025.

  • D.E. Shaw & Co reported no remaining Biomea Fusion position as of Q2 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 45,238 Biomea Fusion shares in Q2 2025, an estimated $96.4K.
  • D.E. Shaw & Co first reported a position in Biomea Fusion in Q4 2021 and held it in 9 quarters.
  • D.E. Shaw & Co's Biomea Fusion position peaked at $6.75M in Q1 2023.
  • 87 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2025.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.